Q . All of the following drugs can cause Neuroleptic Malignant syndrome (NMS) except :
a. Amantadine
b. Domperidone
c. Haloperidol
d. Metoclopramide
ANSWER:
Ans is A (amantadine) not B...
Domperidone may cause NMS though rarely... BUT AMANTADINE NEVER CAUSES NMS (its withdrawal can cause)..
This question is given wrongly in many MCQ books.
True for Digoxin induced arrythmias are All except a. Biventricular Tachycardia b. Paroxysmal Atrial Tachycardia with variable AV block c. Ventricular Bigeminy d. May be used to regularize atrial fibrillation.
Q.Which of the following antihypertensive drugs is contraindicated in a patient on Lithium in order to prevent toxicity?
A. Diuretics B. Beta blockers
C. Calcium channel blockers
D. Clonidine
"Monday disease" is related to which drug?
a)Spironolactone
b)Digoxin
c)Nitroglycerin
d)Hydrochlorothiazide
ANSWER:
Ans-C Monday disease is a toxicity that happens to those who are exposed to Nitroglycerin or isosorbide dinitrate industrially, like who work in construction or demolition industries, mix concrete, do plaster, ect.
During the week, Monday to Friday, they are exposed to the vasodilating action, so they build up a tolerance. If they are off on Saturday and Sunday the tolerance is lost. So when they go back to work on Monday the tachycardia, hypotension, flusing and headache return, but a tolerance is built up again by the next day.
Q.Which of the following is used in the therapy of toxoplasmosis? a. Artensenuate b. Ciprofloxacin
c. Pyrimethamine d. Thiacetazone
ANSWER:
Answer: C
Toxoplasma gondii is an obligate intracellular parasite. It is one of the most common human parasites in the world. Combination of pyrimethamine and a sulfonamide is effective against acute toxoplasmosis in immunocompetent adults. These 2 drugs work synergistically against the tachyzoite form of T gondii. As an alternative to sulphonamides, clindamycin may be beneficial when used in combination with pyrimethamine.
Q. PROVENGE is a vaccine treatment for which of the following cancer
a. hepatoma
b. multiple myeloma
c. prostate cancer
d. hodgkin lymphoma
ANSWER:
answer: C
Provenge (generic name sipuleucel-T) is an immunotherapy for prostate cancer manufactured by Dendreon. It received U.S. Food and Drug Administration (FDA) approval for use in the treatment of advanced prostate cancer patients on April 29, 2010. It is the first FDA approved drug in its class.
To Search for a "particular word" on"the page on your screen" , press Ctrl + F and then type the word you need to search on the visible page.
eg: If you need to search the word "Anatomy" on this page -- Press "Ctrl + F" , (a box will appear) and then type Anatomy in the box that has appeared.